Status:
COMPLETED
Magnetic Nanoparticles System in Acute Coronary Syndrome
Lead Sponsor:
Far Eastern Memorial Hospital
Collaborating Sponsors:
National Taiwan University Hospital
Conditions:
Acute Coronary Syndrome
Eligibility:
All Genders
20-90 years
Brief Summary
To improve the sensitivity and specificity of immunoassay, the developing trends are to lower the detection threshold and to minimize the cross reaction. A new assay technology called immunomagnetic r...
Detailed Description
To improve the sensitivity and specificity of immunoassay, the developing trends are to lower the detection threshold and to minimize the cross reaction. A new assay technology called immunomagnetic r...
Eligibility Criteria
Inclusion
- Diagnosis with acute coronary syndrome
Exclusion
- none
Key Trial Info
Start Date :
February 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
455 Patients enrolled
Trial Details
Trial ID
NCT02226523
Start Date
February 1 2014
End Date
December 1 2022
Last Update
July 26 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Far Eastern Memorial Hospital
New Taipei City, Taiwan, 220
2
National Taiwan University Hospital
Taipei, Taiwan, 100
3
Taoyuan General Hospital, Ministry of Health and Welfare
Taoyuan District, Taiwan, 33004